Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19.
Gene. 2021 Jan 15;766:145145. doi: 10.1016/j.gene.2020.145145. Epub 2020 Sep 14.
Gene. 2021.
PMID: 32941953
Free PMC article.